Matches in SemOpenAlex for { <https://semopenalex.org/work/W2049203909> ?p ?o ?g. }
- W2049203909 endingPage "1905" @default.
- W2049203909 startingPage "1897" @default.
- W2049203909 abstract "The proliferation of vascular smooth muscle cells (VSMCs) induced by injury to the intima of arteries is an important etiologic factor in vascular proliferative disorders such as atherosclerosis and restenosis. Esculetin, derived from the Chinese herb Artemisia scoparia, is well known as a lipoxygenase inhibitor. We have investigated the inhibitory effects of esculetin on VSMC proliferation and intimal hyperplasia by balloon angioplasty in the rat. We determined, using [3H]thymidine incorporation and the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, that esculetin inhibited the proliferation of VSMCs via a lipoxygenase-independent pathway. Three predominant signaling pathways were identified to be inhibited by esculetin: (a) the activation of p42/44 mitogen-activated protein kinase (MAPK) and the downstream effectors of c-fos and c-jun immediate early genes by means of western and reverse transcription-polymerase chain reaction (RT-PCR) analyses; (b) the activation of nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1), using the electrophoretic mobility shift assay; and (c) the activation of phosphoinositide 3-kinase (PI 3-kinase) and cell cycle progression, by western blot analysis and flow cytometric detection. Furthermore, esculetin also profoundly inhibited Ras activation, a shared upstream event of the above signaling cascades. In vascular injury studies, intraperitoneal administration of esculetin significantly suppressed intimal hyperplasia induced by balloon angioplasty. We conclude that esculetin blocks cell proliferation via the inhibition of an upstream effector of Ras and downstream events including p42/44 MAPK activation, PI 3-kinase activation, immediate early gene expression, as well as NF-kappaB and AP-1 activation. It also inhibits intimal hyperplasia after balloon vascular injury in the rat, indicating the therapeutic potential for treating restenosis after arterial injury." @default.
- W2049203909 created "2016-06-24" @default.
- W2049203909 creator A5016825023 @default.
- W2049203909 creator A5019635480 @default.
- W2049203909 creator A5049312136 @default.
- W2049203909 creator A5057812012 @default.
- W2049203909 creator A5075967549 @default.
- W2049203909 creator A5080700826 @default.
- W2049203909 date "2003-06-01" @default.
- W2049203909 modified "2023-10-17" @default.
- W2049203909 title "Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats" @default.
- W2049203909 cites W1992393431 @default.
- W2049203909 cites W1995203720 @default.
- W2049203909 cites W1996160829 @default.
- W2049203909 cites W1999441881 @default.
- W2049203909 cites W2029566146 @default.
- W2049203909 cites W2031220512 @default.
- W2049203909 cites W2031272027 @default.
- W2049203909 cites W2036451354 @default.
- W2049203909 cites W2051897494 @default.
- W2049203909 cites W2052327144 @default.
- W2049203909 cites W2056951304 @default.
- W2049203909 cites W2058184498 @default.
- W2049203909 cites W2061512564 @default.
- W2049203909 cites W2069267604 @default.
- W2049203909 cites W2078856910 @default.
- W2049203909 cites W2085593164 @default.
- W2049203909 cites W2086705127 @default.
- W2049203909 cites W2094036848 @default.
- W2049203909 cites W2095152292 @default.
- W2049203909 cites W2106877484 @default.
- W2049203909 cites W2137570167 @default.
- W2049203909 cites W2146914213 @default.
- W2049203909 cites W2158135412 @default.
- W2049203909 cites W2158324497 @default.
- W2049203909 cites W2394700190 @default.
- W2049203909 cites W4294216491 @default.
- W2049203909 doi "https://doi.org/10.1016/s0006-2952(03)00161-8" @default.
- W2049203909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12781342" @default.
- W2049203909 hasPublicationYear "2003" @default.
- W2049203909 type Work @default.
- W2049203909 sameAs 2049203909 @default.
- W2049203909 citedByCount "63" @default.
- W2049203909 countsByYear W20492039092012 @default.
- W2049203909 countsByYear W20492039092013 @default.
- W2049203909 countsByYear W20492039092014 @default.
- W2049203909 countsByYear W20492039092015 @default.
- W2049203909 countsByYear W20492039092016 @default.
- W2049203909 countsByYear W20492039092017 @default.
- W2049203909 countsByYear W20492039092018 @default.
- W2049203909 countsByYear W20492039092019 @default.
- W2049203909 countsByYear W20492039092020 @default.
- W2049203909 countsByYear W20492039092021 @default.
- W2049203909 countsByYear W20492039092022 @default.
- W2049203909 crossrefType "journal-article" @default.
- W2049203909 hasAuthorship W2049203909A5016825023 @default.
- W2049203909 hasAuthorship W2049203909A5019635480 @default.
- W2049203909 hasAuthorship W2049203909A5049312136 @default.
- W2049203909 hasAuthorship W2049203909A5057812012 @default.
- W2049203909 hasAuthorship W2049203909A5075967549 @default.
- W2049203909 hasAuthorship W2049203909A5080700826 @default.
- W2049203909 hasConcept C126322002 @default.
- W2049203909 hasConcept C134018914 @default.
- W2049203909 hasConcept C153911025 @default.
- W2049203909 hasConcept C184235292 @default.
- W2049203909 hasConcept C185592680 @default.
- W2049203909 hasConcept C2778283817 @default.
- W2049203909 hasConcept C2778583881 @default.
- W2049203909 hasConcept C2779395532 @default.
- W2049203909 hasConcept C2992686903 @default.
- W2049203909 hasConcept C55493867 @default.
- W2049203909 hasConcept C57074206 @default.
- W2049203909 hasConcept C62112901 @default.
- W2049203909 hasConcept C62478195 @default.
- W2049203909 hasConcept C71924100 @default.
- W2049203909 hasConcept C86803240 @default.
- W2049203909 hasConcept C95444343 @default.
- W2049203909 hasConcept C98274493 @default.
- W2049203909 hasConceptScore W2049203909C126322002 @default.
- W2049203909 hasConceptScore W2049203909C134018914 @default.
- W2049203909 hasConceptScore W2049203909C153911025 @default.
- W2049203909 hasConceptScore W2049203909C184235292 @default.
- W2049203909 hasConceptScore W2049203909C185592680 @default.
- W2049203909 hasConceptScore W2049203909C2778283817 @default.
- W2049203909 hasConceptScore W2049203909C2778583881 @default.
- W2049203909 hasConceptScore W2049203909C2779395532 @default.
- W2049203909 hasConceptScore W2049203909C2992686903 @default.
- W2049203909 hasConceptScore W2049203909C55493867 @default.
- W2049203909 hasConceptScore W2049203909C57074206 @default.
- W2049203909 hasConceptScore W2049203909C62112901 @default.
- W2049203909 hasConceptScore W2049203909C62478195 @default.
- W2049203909 hasConceptScore W2049203909C71924100 @default.
- W2049203909 hasConceptScore W2049203909C86803240 @default.
- W2049203909 hasConceptScore W2049203909C95444343 @default.
- W2049203909 hasConceptScore W2049203909C98274493 @default.
- W2049203909 hasIssue "11" @default.
- W2049203909 hasLocation W20492039091 @default.
- W2049203909 hasLocation W20492039092 @default.